<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ssmu</journal-id><journal-title-group><journal-title xml:lang="ru">Бюллетень сибирской медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of Siberian Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-0363</issn><issn pub-type="epub">1819-3684</issn><publisher><publisher-name>Siberian State Medical University, the Ministry of Healthcare of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20538/1682-0363-2017-1-101-107</article-id><article-id custom-type="elpub" pub-id-type="custom">ssmu-779</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>Экспериментальная апробация нового эхоконтрастного препарата на основе гексафторида серы в диагностике очаговых образований печени воспалительного генеза</article-title><trans-title-group xml:lang="en"><trans-title>Experimental approbation of a new ultrosound contrast agent based on sulfur geksafluoride in diagnostics of focal liver lesions of inflammatory genesis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фомина</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Fomina</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач отделения ультразвуковой диагностики,</p><p>634050, г. Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>Doctor of the Department Ultrasonic Diagnosis,</p><p>2, Moscow Trakt, Tomsk, 634050</p></bio><email xlink:type="simple">statfom@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Завадовская</surname><given-names>В. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Zavadovskay</surname><given-names>V. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, профессор кафедры лучевой диагностики и лучевой терапии,</p><p>634050, г. Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>DM, Professor, Department of Radiation Diagnostics and Radiation Therapy,</p><p>2, Moscow Trakt, Tomsk, 634050</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чурин</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Churin</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, зав. отделением лекарственной токсикологии,</p><p>634028, г. Томск, пр. Ленина, 3</p></bio><bio xml:lang="en"><p>DM, Head of the Department of Drug Toxicology,</p><p>3, Lenina, Tomsk, 634050</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Юсубов</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Jusubov</surname><given-names>M. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р хим. наук, профессор кафедры химии,</p><p>634050, г. Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>DChS, Professor of the Department of Chemistry,</p><p>2, Moscow Trakt, Tomsk, 634050</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Сибирский государственный медицинский университет (СибГМУ)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Siberian Medical State University (SSMU)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>НИИ фармакологии и регенеративной медицины имени Е.Д. Гольдберга (НИИФиРМ им. Е.Д. Гольдберга), Томский национальный исследовательский медицинский центр (ТНИМЦ) Российской академии наук (РАН)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute of Pharmacology and Regenerative Medicine named E.D. Goldberg, Tomsk National Research Medical Center (TNRMC), Russian Academy of Sciences (RAS)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>20</day><month>04</month><year>2017</year></pub-date><volume>16</volume><issue>1</issue><fpage>101</fpage><lpage>107</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Фомина С.В., Завадовская В.Д., Чурин А.А., Юсубов М.С., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Фомина С.В., Завадовская В.Д., Чурин А.А., Юсубов М.С.</copyright-holder><copyright-holder xml:lang="en">Fomina S.V., Zavadovskay V.D., Churin A.A., Jusubov M.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://bulletin.ssmu.ru/jour/article/view/779">https://bulletin.ssmu.ru/jour/article/view/779</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования. Экспериментальная апробация нового отечественного эхоконтрастного препарата (ЭКП) на основе гексафторида серы в диагностике очаговых образований печени воспалительного генеза.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Исследуемый эхоконтрастный препарат представлял собой гетерогенную систему «газ – жидкость», состоящую из микропузырьков слаборастворимого газа гексафторида серы (SF6), окруженных гибкой мобильной мембраной из поверхностно-активных веществ. Экспериментальная работа проведена на кроликах. Исследуемая группа включала кроликов самцов и самок с очаговым поражением печени воспалительного генеза (n = 12) массой 1500–1700 г. ЭКП вводили животным в ушную вену. Очаговые поражения печени у животных создавали в условиях экспериментальной операционной лаборатории. Через 14 сут после операции всем животным проводили ультразвуковое исследование (УЗИ) зоны оперативных вмешательств на сканерах Toshiba Aplio 400 (Япония) конвексным датчиком частотой 3,5–8 МГц. При нативном исследовании проводили оценку размеров, структуры и эхогенности очага, определяли степень васкуляризации, ровность и четкость контуров. При постконтрастном УЗИ регистрировали время начала контрастного усиления, общую длительность контрастирования, оценивали изменения контрастного усиления очага в разные фазы исследования, измеряли размеры очага, оценивали ровность и четкость контуров. Для гистологического исследования использовали фрагменты печени (в непосредственной близости от инородного тела и на удалении от него) и легких.</p></sec><sec><title>Результаты</title><p>Результаты. Продемонстрирована высокая специфическая эффективность отечественного ЭКП, что подтверждается контрастным усилением, которое регистрировалось с 3–6-й с и длилось 3–4 мин у всех животных. Очаговые образования печени воспалительного генеза (абсцессы) визуализировались у всех животных как неконтрастные на протяжении фаз исследования (артериальная, портальная, поздняя), с неоднородной аваскулярной структурой, с гиперэхогенным ободком, что соответствует их патоморфологической структуре.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose of the study</title><p>Purpose of the study. Experimental approbation of a new domestic ultrasound contrast agent (UCA) based on sulfur hexafluoride in the diagnosis of focal liver lesions of inflammatory genesis.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The investigated ultrasound contrast agent (UCA) was a heterogeneous gas-liquid system consisting of micro bubbles of a sparingly soluble gas of sulfur hexafluoride (SF6) surrounded by a flexible mobile membrane of surfactants. Experimental work was carried out on rabbits. The study group included rabbits of males and females with focal liver lesion of inflammatory genesis (n = 12) weighing 1500- 1700 g. UCA was administered to animals in the ear vein. Focal lesions of the liver in animals were created in the experimental laboratory conditions. 14 days after the operation, all animals were subjected to ultrasound examination of the surgical intervention zones by using the Toshiba Aplio 400 scanners (Japan) with a 3,5–8 MHz convection sensor. In a natural study, the size, structure and echogenicity of the focus were assessed, the degree of vascularization, the evenness and clarity of the contours were determined. When performing post contrast ultrasound, the time of the onset of contrast enhancement, the total duration of contrast, the changes in the contrast enhancement of the focus in different phases of the study were measured, the dimensions of the focus were measured, and the evenness and acuity of contours were measured. For histological examination, liver fragments and lungs were used. </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>ультразвуковая диагностика</kwd><kwd>эхоконтрастные препараты</kwd><kwd>микропузырьки</kwd><kwd>пофазное контрастирование</kwd><kwd>акустическое сопротивление</kwd><kwd>очаговые образования</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ultrasound diagnosis</kwd><kwd>echocontrast preparations</kwd><kwd>microbubbles</kwd><kwd>phasic contrasting</kwd><kwd>acoustic resistance</kwd><kwd>focal formations</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">ГК № 14.N08.12.0027</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Митьков В.В. Практическое руководство по ультразвуковой диагностике. Общая ультразвуковая диагностика: учеб. для вузов. 2-е изд., перераб. и доп. М.: Видар, 2011: 720.</mixed-citation><mixed-citation xml:lang="en">Mitkov V.V. Prakticheskoye rukovodstvo po ul’trazvukovoy diagnostike. Obshchaya ul’trazvukovaya diagnostika: ucheb. dlya vuzov [Practical guidance on ultrasound diagnostics. General ultrasound diagnosis: textbook for universities]. M.: Vidar. Publ., 2011: 720 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ультразвуковая диагностика сосудистых заболеваний: учеб.-метод. пособие / В.П. Куликов, Л.Э. Шульгина, М.Л. Дическул и др. М.: Стром, 2011: 512.</mixed-citation><mixed-citation xml:lang="en">Kulikov V.P., Shul’gina L.E., Dicheskul M.L. i dr. Ul’trazvukovaya diagnostika sosudistykh zabolevaniy: ucheb.-metod. posobiye [Ultrasonic diagnostics of vascular diseases: a teaching method]. M.: Strom Publ., 2011: 512 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Greis C. Contrast-enhanced ultrasound in general imaging. Italia, Springer-Verlag, 2005: 326.</mixed-citation><mixed-citation xml:lang="en">Greis C. Contrast-Enhanced Ultrasound in General Imaging. Italia, Springer-Verlag, 2005: 326.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Quasia E. Microbubblebultrasound contrast agents: an update // Eur. Radiol. 2007; 17 (8): 1995–2008.</mixed-citation><mixed-citation xml:lang="en">Quasia E. Microbubblebultrasound contrast agents: an update. // Eur. Radiol. 2007;. 17 (8): 1995–2008.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lencioni R. Enhancing the Role of Ultrasound with Contrast Agents. Italia, Springer-Verlag, 2009: 378.</mixed-citation><mixed-citation xml:lang="en">Lencioni R. Enhancing the Role of Ultrasound with Contrast Agents. Italia, Springer-Verlag, 2009: 378.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Atri M., Gertner M.R., Haider M.A. et al. Contrast-Enhanced ultrasonography for real-time monitoring of interstitial laser thermal therapy in the focal treatment of prostate cancer // CUAJ. 2009; 3: 38–44.</mixed-citation><mixed-citation xml:lang="en">Atri M., Gertner M.R., Haider M.A. et al. Contrast-Enhanced Ultrasonography for Real-time Monitoring of Interstitial Laser Thermal Therapy in the Focal Treatment of Prostate Cancer // CUAJ. 2009; 3: 38–44.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Badea A.F., Tamas-Szora A., Clichici S. Contrast enhanced ultrasonography (CEUS) in the characterization of tumor microcirculation. Validation of the procedure in the animal experimental model // Med. Ultrason. 2013. 15 (2): 85–94.</mixed-citation><mixed-citation xml:lang="en">Badea A.F., Tamas-Szora A., Clichici S. Contrast enhanced ultrasonography (CEUS) in the characterization of tumor microcirculation. Validation of the procedure in the animal experimental model // Med. Ultrason. 2013. 15 (2): 85–94.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Takada H., Tsuchiya K., Yasui Y. et al. Сomparison of сontrast-уnhanced гltrasound and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MRI for the diagnosis of macroscopic type of hepatocellular carcinoma // Cancer Med. 2016. 5 (11): 3111–3120.</mixed-citation><mixed-citation xml:lang="en">Takada H., Tsuchiya K., Yasui Y. et al. Сomparison of сontrast-уnhanced гltrasound and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MRI for the diagnosis of macroscopic type of hepatocellular carcinoma // Cancer Med. 2016. 5 (11): 3111–3120.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ueda N., Nagira H., Sannomiya N. et al. Contrast-enhanced ultrasonography in evaluation of the therapeutic effect of chemotherapy for patients with liver metastases // Yonago Acta Med. 2016; 26: 255–261.</mixed-citation><mixed-citation xml:lang="en">Ueda N., Nagira H., Sannomiya N. et al. Contrast-enhanced ultrasonography in evaluation of the therapeutic effect of chemotherapy for patients with liver metastases // Yonago Acta Med. 2016; 26: 255–261.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Pfister K., Rennert J., Uller W. et al. Contrast harmonic imaging ultrasound and perfusion imaging for surveillance after endovascular abdominal aneurysm repair regarding detection and characterization of suspected endoleaks // Clin Hemorheol Microcirc. 2009; 43: 119–128.</mixed-citation><mixed-citation xml:lang="en">Pfister K., Rennert J., Uller W. et al. Contrast harmonic imaging ultrasound and perfusion imaging for surveillance after endovascular abdominal aneurysm repair regarding detection and characterization of suspected endoleaks // Clin Hemorheol Microcirc. 2009; 43: 119–128.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Dong Y., Wang W.P., Mao F. et al. Contrast enhanced ultrasound features of hepatic cystadenoma and hepatic cystadenocarcinoma // Gastroenterol. 2017; 52 (3): 365–372.</mixed-citation><mixed-citation xml:lang="en">Dong Y., Wang W.P., Mao F. et al. Contrast enhanced ultrasound features of hepatic cystadenoma and hepatic cystadenocarcinoma // Gastroenterol. 2017; 52 (3): 365–372.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Streba C.T., Ionescu M., Gheonea D.I. et al.Contrast-enhanced ultrasonography parameters in neural network diagnosis of liver tumors // World J Gastroenterol. 2012; 18 (32): 4427–4434.</mixed-citation><mixed-citation xml:lang="en">Streba C.T., Ionescu M., Gheonea D.I. et al.Contrast-enhanced ultrasonography parameters in neural network diagnosis of liver tumors // World J Gastroenterol. 2012; 18 (32): 4427–4434.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
